TY - JOUR T1 - The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019 JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2020-000921 VL - 8 IS - 2 SP - e000921 AU - Paolo A Ascierto AU - Carlo Bifulco AU - Jerome Galon AU - Claus Garbe AU - Samir N Khleif AU - Jennifer McQuade AU - Kunle Odunsi AU - Hideho Okada AU - Chrystal M Paulos AU - Sergio A Quezada AU - Hussein A Tawbi AU - John Timmerman AU - Giorgio Trinchieri AU - Lisa H Butterfield AU - Igor Puzanov Y1 - 2020/08/01 UR - http://jitc.bmj.com/content/8/2/e000921.abstract N2 - As part of the 2019 Immunotherapy Bridge congress (December 4–5, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on six topical issues in immunotherapy today. These were the use of chimeric antigen receptor T cell therapy in solid tumors, whether the Immunoscore should be more widely used in clinical practice, whether antibody-dependent cellular cytotoxicity is important in the mode of action of anticytotoxic T-lymphocyte-associated protein 4 antibodies, whether the brain is immunologically unique or just another organ, the role of microbiome versus nutrition in affecting responses to immunotherapy, and whether chemotherapy is immunostimulatory or immunosuppressive. Discussion of these important topics are summarized in this report. ER -